The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: A study protocol

Trials

Volumn 10, Issue , 2009, Pages

  Pedrazzini, Baptiste ^a   Waldvogel, Sophie ^b   Cornuz, Jacques ^a   Vaucher, Paul ^a   Bize, Raphael ^a   Tissot, Jean Daniel ^b   Pecoud, Alain ^a   Favrat, Bernard ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Blood Transfusion Service of the Swiss Red Cross   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERROUS SULFATE; HEMOGLOBIN; PLACEBO; BIOLOGICAL MARKER; FERROUS ION; IRON;

ADULT; AEROBIC CAPACITY; ANEMIA; ARTICLE; BLOOD DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MENSTRUATION; MOOD DISORDER; PATIENT MONITORING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF REPORT; SWITZERLAND; TREATMENT DURATION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; AFFECT; BLOOD; DOWN REGULATION; DRUG EFFECT; EXERCISE TOLERANCE; METABOLISM; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADMINISTRATION, ORAL; AFFECT; BIOLOGICAL MARKERS; BLOOD DONORS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DOWN-REGULATION; EXERCISE TOLERANCE; FATIGUE; FEMALE; FERRITINS; FERROUS COMPOUNDS; HEMOGLOBINS; HUMANS; IRON; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 60849092553     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-10-4     Document Type: Article

References (18)

1. Beutler E Larsh SE Gruney CW: Iron therapy in chronically fatigued, nonanemic women: A double-blind study. Ann Intern Med 1960, 52:378-394. 13800263
2. Bruner AB Joffe A Duggan AK Casella JF Brandt J: Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996, 348:992-996. 10.1016/ S0140-6736(96)02341-0 8855856
3. Patterson AJ Brown WJ Powers JR Roberts DC: Iron deficiency, general health and fatigue: Results from the Australian Longitudinal Study on Women's Health. Qual Life Res 2000, 9:491-497. 10.1023/A:1008978114650 11190004
4. Patterson AJ Brown WJ Roberts DC: Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age. J Am Coll Nutr 2001, 20:337-342. 11506061
5. Verdon F Burnand B Stubi CL Bonard C Graff M Michaud A et al: Iron supplementation for unexplained fatigue in non-anaemic women: Double blind randomised placebo controlled trial. BMJ 2003, 326:1124. 156009 12763985 10.1136/bmj.326.7399.1124
6. Brownlie T Utermohlen V Hinton PS Giordano C Haas JD: Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr 2002, 75:734-742. 11916761
7. Newman BH Roth AJ: Estimating the probability of a blood donation adverse event based on 1000 interviewed whole-blood donors. Transfusion 2005, 45:1715-1721. 10.1111/j.1537-2995.2005.00595.x 16271095
8. Newman BH Newman DT Ahmad R Roth AJ: The effect of whole-blood donor adverse events on blood donor return rates. Transfusion 2006, 46:1374-1379. 10.1111/j.1537-2995.2006.00905.x 16934074
9. Maghsudlu M Nasizadeh S Toogeh GR Zandieh T Parandoush S Rezayani M: Short-term ferrous sulfate supplementation in female blood donors. Transfusion 2008, 48:1192-7. 10.1111/j.1537-2995.2007.01671.x 18363581
10. Magnussen K Bork N Asmussen L: The effect of a standardized protocol for iron supplementation to blood donors low in hemoglobin concentration. Transfusion 2008, 48:749-754. 10.1111/j.1537-2995.2007.01601.x 18194390
11. Krupp LB LaRocca NG Muir-Nash J Steinberg AD: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46:1121-1123. 2803071
12. Gandek B Ware JE Aaronson NK Apolone G Bjorner JB Brazier JE et al: Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1171-1178. 10.1016/ S0895-4356(98)00109-7 9817135
13. Spitzer RL Kroenke K Williams JB; Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999, 282:1737-1744. 10.1001/jama.282.18.1737 10568646
14. Sykes K Roberts A: The Chester step test-a simple yet effective tool for the prediction of aerobic capacity. Physiotherapy 2004, 90:183-188. 10.1016/j.physio.2004.03.008
15. Janssen CA Scholten PC Heintz AP: A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995, 85:977-982. 10.1016/0029-7844(95)00062-V 7770270
16. Averbuch M Weintraub M Pollock DJ: Compliance assessment in clinical trials: The MEMS device. J Clin Res Pharmacoepidemiol 1990, 4:199-204.
17. Fallab-Stubi CL Zellweger JP Sauty A Uldry C Iorillo D Burnier M: Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis 1998, 2:525-530. 9661817
18. Todd KH Funk KG Funk JP Bonacci R: Clinical significance of reported changes in pain severity. Ann Emerg Med 1996, 27:485-489. 10.1016/ S0196-0644(96)70238-X 8604867